A clinician will assess medical history, metabolic health, treatment tolerance, and long-term goals before recommending the most suitable option
Since retatrutide is still in clinical trials and not yet FDA approved, we do not know the full picture, but based on what we know so far, the following people would not be good candidates: Individuals with a personal or family history of medullary thyroid cancer or MEN 2 (Multiple Endocrine Neoplasia syndrome type 2) Individuals with certain medical conditions, like pancreatitis
As such, youre prone to dehydration and the loss of critical nutrients and minerals
Transparency in sharing your complete health history will assist your healthcare provider in making informed decisions for your care
In-Person Work
For others, it may be something they take for a shorter period of time (think: a few months to a few years)